MONTRÉAL – Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) reported the latest achievements of its largest holding Little Green Pharma Ltd. LGP has achieved the following major milestone validating their investment:
The French Agency for the Safety of Medicines and Health Products (ANSM) has selected Little Green Pharma as 1 of 4 companies that will supply France’s medical cannabis pilot program. Under the program, participants will be provided with free products to patients that enol in the trial. LGP will be both a main & substitute supplier for CBD sublingual oils.
Currently, Elixxer holds 27.4M shares of LGP and as of January 27, 2021 the closing price was $0.64 per share on the ASX.
Elixxer says it will update the investors via press release on further developments from its holdings.
Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).
Through its partners, Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.
We seek Safe Harbor.
